Plavix
Sponsors
Washington University School of Medicine, Cogentus Pharmaceuticals, University of Pecs, Royal Brompton & Harefield NHS Foundation Trust, Les Laboratoires des Médicaments Stériles
Conditions
Acute Coronary SyndromeBreast NeoplasmsCardiovascular DiseaseCoronary DiseaseCoronary Heart DiseaseHealthyPercutaneous Coronary InterventionPharmacokinetics and Pharmacodynamics in Healthy Volunteers
Phase 1
Pharmacodynamics of CGT 2168 Compared With Plavix®
CompletedNCT00620802
Start: 2007-11-30End: 2008-05-31Updated: 2008-08-26
Appraisal of MDCO-157 and Plavix® Pharmacokinetics and Pharmacodynamics in Healthy Volunteers With an Evaluation
CompletedNCT01860105
Start: 2012-09-30End: 2013-01-31Updated: 2018-02-22
Phase 2
Phase 4
Comparison of Generic and Original Formulation of Clopidogrel
CompletedNCT01147133
Start: 2009-11-30End: 2010-05-31Updated: 2013-01-29
Evaluating Additional Platelet Inhibition in Patients With High Platelet Reactivity Undergoing Percutaneous Coronary Intervention
TerminatedNCT01339026
Start: 2012-02-29End: 2013-09-30Updated: 2014-09-18
Clinical Assessment of Pidogrel® Versus Plavix® (CAPP)
CompletedNCT01431495
Start: 2010-04-30End: 2011-07-31Updated: 2011-09-09